Ultrasound-guided transfection of claudin-5 improves lung endothelial barrier function in lung injury without impairing innate immunity.
claudin-5
endothelial barrier
lung injury
transfection
vascular leakage
Journal
American journal of physiology. Lung cellular and molecular physiology
ISSN: 1522-1504
Titre abrégé: Am J Physiol Lung Cell Mol Physiol
Pays: United States
ID NLM: 100901229
Informations de publication
Date de publication:
01 08 2023
01 08 2023
Historique:
medline:
14
7
2023
pubmed:
13
6
2023
entrez:
13
6
2023
Statut:
ppublish
Résumé
In acute lung injury, the lung endothelial barrier is compromised. Loss of endothelial barrier integrity occurs in association with decreased levels of the tight junction protein claudin-5. Restoration of their levels by gene transfection may improve the vascular barrier, but how to limit transfection solely to regions of the lung that are injured is unknown. We hypothesized that thoracic ultrasound in combination with intravenous microbubbles (USMBs) could be used to achieve regional gene transfection in injured lung regions and improve endothelial barrier function. Since air blocks ultrasound energy, insonation of the lung is only achieved in areas of lung injury (edema and atelectasis); healthy lung is spared. Cavitation of the microbubbles achieves local tissue transfection. Here we demonstrate successful USMB-mediated gene transfection in the injured lungs of mice. After thoracic insonation, transfection was confined to the lung and only occurred in the setting of injured (but not healthy) lung. In a mouse model of acute lung injury, we observed downregulation of endogenous claudin-5 and an acute improvement in lung vascular leakage and in oxygenation after claudin-5 overexpression by transfection. The improvement occurred without any impairment of the immune response as measured by pathogen clearance, alveolar cytokines, and lung histology. In conclusion, USMB-mediated transfection targets injured lung regions and is a novel approach to the treatment of lung injury.
Identifiants
pubmed: 37310768
doi: 10.1152/ajplung.00107.2023
pmc: PMC10393345
doi:
Substances chimiques
Claudin-5
0
Tight Junction Proteins
0
Cldn5 protein, mouse
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
L135-L142Subventions
Organisme : CIHR
ID : OV2 170656
Pays : Canada
Organisme : CIHR
ID : CPG-158284
Pays : Canada
Références
Curr Cardiol Rev. 2011 Aug;7(3):157-62
pubmed: 22758614
N Engl J Med. 2000 May 4;342(18):1301-8
pubmed: 10793162
JAMA. 2016 Feb 23;315(8):788-800
pubmed: 26903337
Arterioscler Thromb Vasc Biol. 2015 Nov;35(11):2401-11
pubmed: 26381870
Am J Respir Crit Care Med. 2019 Dec 15;200(12):1472-1476
pubmed: 31381867
Methods Mol Biol. 2021;2367:137-148
pubmed: 33460025
PLoS One. 2016 Jun 08;11(6):e0156754
pubmed: 27275866
Front Pharmacol. 2020 Jan 16;10:1562
pubmed: 32009963
PLoS One. 2012;7(10):e47323
pubmed: 23115643
Sci Rep. 2015 Jun 05;5:11030
pubmed: 26046800
Intensive Care Med. 1998 Dec;24(12):1331-4
pubmed: 9885889
Am J Physiol Lung Cell Mol Physiol. 2019 May 1;316(5):L740-L750
pubmed: 30702342
Biomedicines. 2021 Jul 12;9(7):
pubmed: 34356867
Ultrasound Med Biol. 2003 Dec;29(12):1759-67
pubmed: 14698343
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
Am J Respir Cell Mol Biol. 2011 May;44(5):725-38
pubmed: 21531958
Viruses. 2021 Jan 22;13(2):
pubmed: 33499234
J Clin Invest. 2012 Aug;122(8):2731-40
pubmed: 22850883
Am J Respir Crit Care Med. 2018 Aug 1;198(3):404-408
pubmed: 29638143
J Virol. 2015 Dec 04;90(4):1812-23
pubmed: 26637453
J Immunol. 2008 May 15;180(10):6947-53
pubmed: 18453616
Am J Respir Cell Mol Biol. 2015 Oct;53(4):459-70
pubmed: 25693001
J Cell Biol. 2003 May 12;161(3):653-60
pubmed: 12743111